- The trend backdrop is active with a 34-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is constructive, supporting the smart-money activity read.
EIQ
ASX
Week ended 07 Aug 2026
Weekly Investor Report
Echo IQ Limited · Healthcare · Health Information Services
Latest close
1.47 AUD
10.9%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 43.2% above the Trend Line and sits at 80.8% of its 52-week range. The latest completed week returned 10.9%, after a -11.4% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100.
Setup score
57
out of 100
Latest Close
1.47 AUD
7 Aug 2026
1W Return
10.9%
latest completed week
4W Return
-11.4%
short-term follow-through
12W Return
27.8%
quarterly tape
Trend Breadth
65.4%
34 of 52 weeks active
Volume Ratio
1.3x
vs 13-week average
- Activity pressure is negative, which weakens the current setup.
- 3 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
10.9%
Latest completed week; four-week move -11.4%.
Indicator stack
81/42
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
4 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 43.2% above the Trend Line and sits at 80.8% of its 52-week range. The latest completed week returned 10.9%, after a -11.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.9012-week average 0.96
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.90Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers
No recent accumulation markers. 3 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -11.4% over four weeks, 27.8% over 12 weeks, and 617.1% over one year. The current trend has remained active for 34 consecutive weeks.
Performance by holding period
Active trend streak34 weeks
Active weeks in one year34
Trend breadth65.4%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.00Latest activity-pressure read.
Pressure change-100.0%Four-week change in activity pressure.
Leadership102.81Latest relative-leadership reading.
RS change-41.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 30 Jun 2025
Field coverage 24%
Model confidence 12%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength92/100Blend of value, momentum, and quality. Underlying universe rank 9; rank 1 is best.
Value80/100Relative valuation strength. Underlying universe rank 21; rank 1 is best.
Quality79/100Profitability and accounting quality. Underlying universe rank 22; rank 1 is best.
Momentum80/100Medium-term price momentum. Underlying universe rank 21; rank 1 is best.
Growth80/100Revenue and earnings growth. Underlying universe rank 21; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- - Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- - Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- - Gross profit retained from each unit of revenue.
- Operating margin
- - Operating profit retained from revenue.
- Free-cash-flow margin
- - Free cash flow generated from revenue.
- Return on invested capital
- - Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- - Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 0/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.0% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- - Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 4 relevant articles.
0 positive · 4 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-17.4%Distance below the 52-week high.
13-week volatility12.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher16 of 2610 weeks finished lower.
Best week+46.9%Week of 27 Mar.
Worst week-14.1%Week of 1 May.
Latest week+10.9%Week of 7 Aug.
Shape of recent returns
Strong gains11
Modest gains5
Flat weeks0
Modest losses2
Sharp losses8
Recent vol12.2%13-week weekly-return volatility.
Base vol14.5%52-week weekly-return volatility.
Up/down split31/21Count of positive and negative weeks in the 52-week window.
Average skew13.1% / -7.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAU Healthcare
4-week rank81 / 100
Group average-0.9%
Trend breadth25.0%
Trend25.0%active weekly trend signals
MD58.0%positive activity pressure
RS26.0%positive relative leadership
Four-week leaders
IndustryAU Health Information Services
4-week rank18 / 25
Group average-5.6%
Trend breadth28.0%
Trend28.0%active weekly trend signals
MD52.0%positive activity pressure
RS28.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape61/100
Trend, activity pressure, participation, and risk combine to a 61/100 tape read.
Indicator analysis82/100Latest 12-week confirmation: trend 12/12, activity pressure 11/12, relative leadership 12/12.
Activity pressure 0.90; 3 reversal markers Factors82/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 18; Small Cap Core rank 29 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 4 relevant articles.
Analysts Expect Breakeven For Echo IQ Limited (ASX:EIQ) Before Long Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1.47 AUD | 10.9% | 1.03 AUD | 0.36 AUD | -0.00 | 102.81 | 14.9M | On |
| 31 Jul 2026 | 1.32 AUD | 0.8% | 0.99 AUD | 0.35 AUD | 0.42 | 95.14 | 14.0M | On |
| 24 Jul 2026 | 1.31 AUD | -12.3% | 0.95 AUD | 0.35 AUD | 0.78 | 104.54 | 16.5M | On |
| 17 Jul 2026 | 1.50 AUD | -9.6% | 0.92 AUD | 0.34 AUD | 1.10 | 140.41 | 18.8M | On |
| 10 Jul 2026 | 1.66 AUD | 0.6% | 0.87 AUD | 0.33 AUD | 0.90 | 176.59 | 22.3M | On |
| 3 Jul 2026 | 1.65 AUD | 3.8% | 0.83 AUD | 0.32 AUD | 0.52 | 186.67 | 6.1M | On |
| 26 Jun 2026 | 1.59 AUD | 29.8% | 0.78 AUD | 0.31 AUD | 0.57 | 192.38 | 7.5M | On |
| 19 Jun 2026 | 1.23 AUD | 6.5% | 0.74 AUD | 0.30 AUD | 0.59 | 134.90 | 1.5M | On |
| 12 Jun 2026 | 1.15 AUD | -10.9% | 0.70 AUD | 0.30 AUD | 0.96 | 129.57 | 2.3M | On |
| 5 Jun 2026 | 1.29 AUD | -4.4% | 0.67 AUD | 0.29 AUD | 1.20 | 172.64 | 11.8M | On |
| 29 May 2026 | 1.35 AUD | -3.6% | 0.64 AUD | 0.28 AUD | 1.12 | 194.55 | 3.9M | On |
| 22 May 2026 | 1.40 AUD | 21.7% | 0.60 AUD | 0.28 AUD | 1.13 | 222.95 | 15.3M | On |
| 15 May 2026 | 1.15 AUD | 12.7% | 0.56 AUD | 0.27 AUD | 1.14 | 179.87 | 10.6M | On |
| 8 May 2026 | 1.02 AUD | 1.5% | 0.53 AUD | 0.26 AUD | 1.23 | 154.77 | 10.4M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.